Hassan M. Rashed

687 total citations
22 papers, 591 citations indexed

About

Hassan M. Rashed is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Biomaterials. According to data from OpenAlex, Hassan M. Rashed has authored 22 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Radiology, Nuclear Medicine and Imaging, 7 papers in Oncology and 7 papers in Biomaterials. Recurrent topics in Hassan M. Rashed's work include Radiopharmaceutical Chemistry and Applications (11 papers), Nanoparticle-Based Drug Delivery (7 papers) and Medical Imaging Techniques and Applications (5 papers). Hassan M. Rashed is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (11 papers), Nanoparticle-Based Drug Delivery (7 papers) and Medical Imaging Techniques and Applications (5 papers). Hassan M. Rashed collaborates with scholars based in Egypt, China and Saudi Arabia. Hassan M. Rashed's co-authors include Rehab Nabil Shamma, Tamer M. Sakr, Ahmed B. Ibrahim, M. A. Motaleb, Ehab R. Bendas, Nevine Shawky Abdelmalak, Marianne J. Naguib, Ahmed Abd El-Bary, Ismail Ibrahim and Emad B. Basalious and has published in prestigious journals such as Molecules, International Journal of Pharmaceutics and European Journal of Medicinal Chemistry.

In The Last Decade

Hassan M. Rashed

22 papers receiving 582 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hassan M. Rashed Egypt 13 233 183 128 125 104 22 591
Pushpa Mishra India 10 376 1.6× 148 0.8× 80 0.6× 88 0.7× 36 0.3× 19 590
Senthil Venkatachalam India 13 127 0.5× 130 0.7× 95 0.7× 131 1.0× 23 0.2× 52 589
Viral Kansara United States 18 125 0.5× 391 2.1× 176 1.4× 55 0.4× 53 0.5× 30 864
Mitan Gokulgandhi United States 14 121 0.5× 287 1.6× 90 0.7× 55 0.4× 28 0.3× 19 603
J.D. Pipkin United States 16 209 0.9× 175 1.0× 34 0.3× 39 0.3× 58 0.6× 34 529
Kenzo Yamamura Japan 16 254 1.1× 158 0.9× 102 0.8× 39 0.3× 45 0.4× 24 625
Pekka Suhonen Finland 14 226 1.0× 217 1.2× 92 0.7× 39 0.3× 43 0.4× 24 609
Ágnes Rusznyák Hungary 10 124 0.5× 121 0.7× 14 0.1× 88 0.7× 39 0.4× 20 409
Sergei Pechenov United States 11 178 0.8× 323 1.8× 95 0.7× 56 0.4× 10 0.1× 19 554

Countries citing papers authored by Hassan M. Rashed

Since Specialization
Citations

This map shows the geographic impact of Hassan M. Rashed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hassan M. Rashed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hassan M. Rashed more than expected).

Fields of papers citing papers by Hassan M. Rashed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hassan M. Rashed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hassan M. Rashed. The network helps show where Hassan M. Rashed may publish in the future.

Co-authorship network of co-authors of Hassan M. Rashed

This figure shows the co-authorship network connecting the top 25 collaborators of Hassan M. Rashed. A scholar is included among the top collaborators of Hassan M. Rashed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hassan M. Rashed. Hassan M. Rashed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rashed, Hassan M., et al.. (2024). Revitalizing Itraconazole: Unleashing its Anticancer Potential through Oral Nanosystems for Liver Targeting and Biodistribution Profiling in an Animal Model using Radiolabeling Technique. Journal of Drug Delivery Science and Technology. 104. 106463–106463. 12 indexed citations
2.
Selim, Adli A., et al.. (2024). Intranasal Radioiodinated Ferulic Acid Polymeric Micelles as the FirstNuclear Medicine Imaging Probe for ETRA Brain Receptor. Current Radiopharmaceuticals. 17(2). 209–217. 2 indexed citations
3.
Selim, Adli A., et al.. (2023). Niosomal formulation of mefenamic acid for enhanced cancer targeting; preparation, characterization and biodistribution study using radiolabeling technique. Journal of Cancer Research and Clinical Oncology. 149(20). 18065–18080. 1 indexed citations
4.
Selim, Adli A., et al.. (2022). Radioiodinated acemetacin loaded niosomes as a dual anticancer therapy. International Journal of Pharmaceutics. 628. 122345–122345. 12 indexed citations
5.
Rashed, Hassan M., et al.. (2022). Multifunctional 99mTc-5-azacitidine Gold Nanoparticles: Formulation,In Vitro Cytotoxicity, Radiosynthesis, and In Vivo Pharmacokinetic Study. Current Drug Delivery. 20(4). 387–399. 3 indexed citations
6.
Ibrahim, Ismail, et al.. (2021). Preparation, characterization, and in vivo biodistribution study of intranasal 131I-clonazepam-loaded phospholipid magnesome as a promising brain delivery system. European Journal of Pharmaceutical Sciences. 169. 106089–106089. 17 indexed citations
7.
Ahmed, Iman Saad, et al.. (2020). Nanoparticle-Mediated Dual Targeting: An Approach for Enhanced Baicalin Delivery to the Liver. Pharmaceutics. 12(2). 107–107. 31 indexed citations
9.
Rashed, Hassan M., et al.. (2019). Superiority of DEAE-Dx-Stabilized Cationic Bile-Based Vesicles over Conventional Vesicles for Enhanced Hepatic Delivery of Daclatasvir. Molecular Pharmaceutics. 16(10). 4190–4199. 9 indexed citations
10.
Nasr, Tamer, Samir Bondock, Hassan M. Rashed, et al.. (2018). Novel hydrazide-hydrazone and amide substituted coumarin derivatives: Synthesis, cytotoxicity screening, microarray, radiolabeling and in vivo pharmacokinetic studies. European Journal of Medicinal Chemistry. 151. 723–739. 67 indexed citations
11.
Rashed, Hassan M., et al.. (2018). Preparation of 99mTc-levetiracetam intranasal microemulsion as the first radiotracer for SPECT imaging of the Synaptic Vesicle Protein SV2A. European Journal of Pharmaceutical Sciences. 121. 29–33. 14 indexed citations
12.
Sakr, Tamer M., Mohammed A. Khedr, Hassan M. Rashed, & Maged E. Mohamed. (2018). In Silico-Based Repositioning of Phosphinothricin as a Novel Technetium-99m Imaging Probe with Potential Anti-Cancer Activity. Molecules. 23(2). 496–496. 23 indexed citations
14.
Rashed, Hassan M., Ismail Ibrahim, & M. A. Motaleb. (2017). 99mTc-hexoprenaline and 131I-dapoxetine: preparation, in silico modeling and biological evaluation as promising lung scintigraphy radiopharmaceuticals. Journal of Radioanalytical and Nuclear Chemistry. 314(2). 1297–1307. 7 indexed citations
15.
Shamma, Rehab Nabil, et al.. (2016). Trans-nasal zolmitriptan novasomes: in-vitro preparation, optimization and in-vivo evaluation of brain targeting efficiency. Drug Delivery. 23(9). 3374–3386. 96 indexed citations
16.
18.
Rashed, Hassan M., Ismail Ibrahim, M. A. Motaleb, & Ahmed Abd El-Bary. (2014). Preparation of radioiodinated ritodrine as a potential agent for lung imaging. Journal of Radioanalytical and Nuclear Chemistry. 300(3). 1227–1233. 35 indexed citations
19.
Motaleb, M. A., M. T. El‐Kolaly, Hassan M. Rashed, & Ahmed Abd El-Bary. (2011). Novel radioiodinated sibutramine and fluoxetine as models for brain imaging. Journal of Radioanalytical and Nuclear Chemistry. 289(3). 915–921. 25 indexed citations
20.
Motaleb, M. A., M. T. El‐Kolaly, Hassan M. Rashed, & Ahmed Abd El-Bary. (2011). Radioiodinated paroxetine, a novel potential radiopharmaceutical for lung perfusion scan. Journal of Radioanalytical and Nuclear Chemistry. 292(2). 629–635. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026